by admin | Jun 25, 2024 | News & Opinions
Dr. Omer Awan MD MPH CIIP – Forbes – Recently, a 12-year-old boy became the first patient with sickle cell disease to begin commercially approved gene therapy that could potentially cure the condition. Read the article – Click...
by admin | Jun 24, 2024 | News & Opinions
by Ian Haydon, University of Washington School of Medicine – Phys.org – Using computer-designed proteins, researchers have now shown they are able to direct human stem cells to form new blood vessels in the lab. This milestone in regenerative medicine...
by admin | Jun 21, 2024 | News & Opinions
By Laurie Kaiser – University of Buffalo – When the myelin sheath that surrounds nerve fibers in the brain and spinal cord becomes damaged, a number of debilitating conditions can result that limit mobility, inhibit independence and reduce life expectancy....
by admin | Jun 20, 2024 | News & Opinions
by Isabella Ciccone, MPH – Nueurology Live – Recently, the FDA granted regenerative medicine advanced therapy (RMAT) designation to uniQure’s investigational Huntington disease (HD) gene therapy AMT-130 based on interim data from a phase 1/2 trial...
by admin | Jun 19, 2024 | News & Opinions
By Ryan Browne – CNBC – PARIS, France — French beauty and cosmetics giant L’Oreal is working on a form of synthetically produced skin that it says will one day be able to “feel” like we do. At the Viva Technology conference in Paris last...
by admin | Jun 18, 2024 | News & Opinions
by Letisia Marquez – City of Hope – Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from...
